Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» GSK2857916
GSK2857916
GSK mulls filings for multiple myeloma drug
Pharmaforum
Fri, 03/22/19 - 10:06 am
GSK
GSK2857916
antibody-drug conjugate
Multiple Myeloma
The 20 Hottest Pipeline Drugs to Watch in 2019
BioSpace
Sun, 01/6/19 - 02:09 pm
VX-659 + tezacaftor + ivacaftor
semaglutide
JCAR017
ARGX-113
aducanumab
elafibranor
NKTR-214
DS-8201
GSK2857916
ozanimod
SGT-001
valoctocogene roxaparvovec
voxelotor
5 Experimental New Drugs That Could Be Worth $47 Billion
Motley Fool
Wed, 06/20/18 - 09:26 am
GSK2857916
GSK
brolucizumab
Novartis
aducanumab
Biogen
upadacatinib
AbbVie
VX-659 + tezacaftor + ivacaftor
Vertex Pharmaceuticals
GSK’s long-quiet cancer R&D group is ready to make some noise as it mounts a breakout late-stage effort
Endpoints
Wed, 01/10/18 - 10:15 am
GSK
R&D
cancer
GSK2857916
BCMA